LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced it will release its 2006 third quarter financial results before the market opens on Monday, November 6, 2006. The company also said that senior management will host an investor conference call that same day at 8:30 a.m. PST/11:30 a.m. EST to review the company’s financial results and operations.
